Transcat, Inc. (NASDAQ:TRNS) Shares Acquired by Royce & Associates LP

Royce & Associates LP lifted its stake in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 1.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 478,581 shares of the scientific and technical instruments company's stock after purchasing an additional 5,327 shares during the quarter. Royce & Associates LP owned about 5.14% of Transcat worth $35,630,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in TRNS. T. Rowe Price Investment Management Inc. grew its stake in shares of Transcat by 178.0% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 518,597 shares of the scientific and technical instruments company's stock worth $54,837,000 after purchasing an additional 332,064 shares during the period. Champlain Investment Partners LLC lifted its holdings in Transcat by 35.7% in the 4th quarter. Champlain Investment Partners LLC now owns 555,650 shares of the scientific and technical instruments company's stock valued at $58,754,000 after purchasing an additional 146,150 shares in the last quarter. Royal Bank of Canada lifted its holdings in shares of Transcat by 328.4% during the 4th quarter. Royal Bank of Canada now owns 173,514 shares of the scientific and technical instruments company's stock worth $18,348,000 after acquiring an additional 133,013 shares during the period. Granahan Investment Management LLC lifted its holdings in shares of Transcat by 132.0% during the 4th quarter. Granahan Investment Management LLC now owns 188,763 shares of the scientific and technical instruments company's stock worth $19,960,000 after acquiring an additional 107,389 shares during the period. Finally, Bessemer Group Inc. lifted its holdings in shares of Transcat by 1,692.4% during the 4th quarter. Bessemer Group Inc. now owns 109,608 shares of the scientific and technical instruments company's stock worth $11,590,000 after acquiring an additional 103,493 shares during the period. 98.34% of the stock is owned by institutional investors and hedge funds.

Transcat Trading Down 0.6%

NASDAQ TRNS traded down $0.49 during mid-day trading on Thursday, hitting $82.48. The company's stock had a trading volume of 11,259 shares, compared to its average volume of 107,942. Transcat, Inc. has a 52-week low of $67.56 and a 52-week high of $143.40. The stock's fifty day simple moving average is $84.11 and its two-hundred day simple moving average is $82.97. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.29 and a quick ratio of 1.87. The firm has a market capitalization of $768.71 million, a P/E ratio of 52.89 and a beta of 0.73.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 EPS for the quarter, missing the consensus estimate of $0.66 by ($0.02). Transcat had a net margin of 5.21% and a return on equity of 6.47%. The business had revenue of $77.13 million during the quarter, compared to analysts' expectations of $76.40 million. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. Research analysts expect that Transcat, Inc. will post 2.3 EPS for the current year.

Analyst Ratings Changes

Several brokerages have recently weighed in on TRNS. Wall Street Zen upgraded shares of Transcat from a "sell" rating to a "hold" rating in a report on Wednesday, May 28th. HC Wainwright reiterated a "buy" rating and set a $116.00 price objective on shares of Transcat in a report on Wednesday, June 25th. Finally, Lake Street Capital began coverage on shares of Transcat in a report on Thursday, July 10th. They set a "buy" rating and a $105.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $112.20.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.